http://www.dana-farber.org/Newsroom/News-Releases/observation-is-safe-cost-saving-in-low-risk-prostate-cancer.aspxDana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and have a better quality of life while reducing health care costs.Dana-Farber Cancer Institute06/17/2013http://www.dana-farber.org/Newsroom/News-Releases/study-paves-way-for-rational-drug-targeting-of-B-cell-lymphomas.aspxA new Dana-Farber study shows a “big picture” view of an overactive B cell receptor (BCR) signaling pathway that drives about one-third of Diffuse Large B-Cell Lymphomas, which could lead to more promising genetic targets for drug development.Dana-Farber Cancer Institute06/10/2013http://www.dana-farber.org/Newsroom/News-Releases/leukemia-lymphoma-society-and-dana-farber-bring-clinical-trials-to-local-communities.aspxThe Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.Dana-Farber Cancer Institute06/06/2013http://www.dana-farber.org/NewsRoom/News-Releases/targeted-therapy-boosts-lung-cancer-outcomes.aspxDana-Farber researchers reported that patients with non-small cell lung cancer (NSCLC) whose tumor cells harbored an abnormal ALK gene responded better to targeted therapy than traditional chemotherapy.Dana-Farber Cancer Institute06/03/2013http://www.dana-farber.org/Newsroom/News-Releases/drug-combination-improves-survival-in-metastatic-melanoma.aspxDana-Farber researchers found that combining the immune stimulator GM-CSF with the antibody drug ipilimumab prolonged survival in patients with metastatic melanoma and reduced the incidence of the most serious side effects.Dana-Farber Cancer Institute06/03/2013http://www.dana-farber.org/News-Releases/young_breast_cancer_patients_often_opt_for_mastectomy.aspxA Dana-Farber and Harvard School of Public Health study finds that most young women with breast cancer chose to have a mastectomy rather than a surgical procedure that would conserve the breast.Dana-Farber Cancer Institute05/31/2013http://www.dana-farber.org/Newsroom/News-Releases/new-protein-targeting-drug-shows-promise-in-early-trial-for-patients-with-high-risk-cll.aspxDana-Farber investigators led a phase 1 trial in which a new oral targeted drug, idelalisib, (GS-1101), showed the potential to stave off the need for additional treatments for relapsed or treatment-resistant CLL.Dana-Farber Cancer Institute05/15/2013http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-mourns-the-passing-of-Emil-Tom-Frei-III-MD.aspxDr. Frei led Dana-Farber from 1973-1980. During the 1950s and 1960s, Dr. Frei became known as the "father of combination chemotherapy" for demonstrating that treatment with multiple chemotherapy agents could produce lasting remissions in children with acute lymphoblastic leukemia.Dana-Farber Cancer Institute05/01/2013http://www.dana-farber.org/Newsroom/News-Releases/Scientists-find-mutation-driving-pediatric-brain-tumors.aspxA type of low-grade but sometimes lethal brain tumor in children has been found to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors.Dana-Farber Cancer Institute04/30/2013http://www.dana-farber.org/Newsroom/News-Releases/Delays-in-diagnosis-worsen-outlook-for-minority-uninsured-pediatric-retinoblastoma-patients-study-finds.aspxWhen the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive course than in other children, probably because of delays in diagnosis, according to researchers at Dana-Farber/Children's Hospital Cancer Center in Boston.Dana-Farber Cancer Institute04/24/2013http://www.dana-farber.org/Newsroom/News-Releases/Majority-of-children-readmitted-to-hospital-following-transplant.aspxAlmost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.Dana-Farber Cancer Institute04/24/2013http://www.dana-farber.org/Newsroom/News-Releases/study-illuminates-biology-behind-promising-therapy-for-graft-versus-host-disease.aspxDana-Farber researchers detail how low doses of interleukin-2 (IL-2) can alleviate chronic graft-versus-host disease (GVHD) and possibly lead to better treatment for other immune disorders.Dana-Farber Cancer Institute04/11/2013http://www.dana-farber.org/Newsroom/News-Releases/Jimmy-Fund-festivities-add-high-note-to-Opening-Day-at-Fenway.aspxCelebrating the 60th anniversary of the partnership between the Boston Red Sox and the Jimmy Fund during the home opener, the Jimmy Fund Chorus joined former and current players for their major league debut.Dana-Farber Cancer Institute04/10/2013http://www.dana-farber.org/Newsroom/News-Releases/Genetic-biomarker-may-help-identify-neuroblastomas-vulnerable-to-novel-class-of-drugs.aspxAn irregularity within many neuroblastoma cells may indicate whether the tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.Dana-Farber Cancer Institute04/09/2013http://www.dana-farber.org/Newsroom/News-Releases/If-you-like-Dana-Farber-you-could-love-an-authentic-Red-Sox-home-jersey-signed-by-Ellsbury.aspxWould you love a chance to win an authentic Boston Red Sox home jersey signed by star outfielder Jacoby Ellsbury? Then "like" Dana-Farber on Facebook.Dana-Farber Cancer Institute04/08/2013http://www.dana-farber.org/Newsroom/News-Releases/some-patients-with-incurable-tumors-and-brca-mutations-respond-to-new-two-drug-combination.aspxDana-Farber scientists find when given together, two orally available experimental drugs – sapacitabine and seliciclib – worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.Dana-Farber Cancer Institute04/07/2013http://www.dana-farber.org/Newsroom/News-Releases/Blood-tests-can-provide-fuller-picture-of-mutations-in-cancer-than-traditional-biopsies-do-research-finds.aspxDana-Farber researchers find blood test can provide fuller picture of cancer mutations in gastrointestinal stromal tumors than biopsy.Dana-Farber Cancer Institute04/06/2013http://www.dana-farber.org/Newsroom/News-Releases/targeted-toxin-active-in-platinum-resistant-ovarian-cancers.aspxDana-Farber researchers find novel antibody-guided drug achieves responses in platinum drug-resistant ovarian cancer.Dana-Farber Cancer Institute04/06/2013http://www.dana-farber.org/Newsroom/News-Releases/Scientists-find-potential-loophole-in-pancreatic-cancer-defenses.aspxDana-Farber scientists found that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.Dana-Farber Cancer Institute03/27/2013http://www.dana-farber.org/Newsroom/News-Releases/Study-finds-molecular-signature-for-rapidly-increasing-form-of-esophageal-cancer.aspxA study by scientists at Dana-Farber Cancer Institute, the Broad Institute, and other research centers, may offer clues to why rates of esophageal adenocarcinomas (EACs) have risen so sharply. The findings, in Nature Genetics, point to an array of abnormal genes and proteins that may be lynchpins of EAC cell growth and therefore serve as targets for new therapies.Dana-Farber Cancer Institute03/24/2013http://www.dana-farber.org/Newsroom/News-Releases/Collaboration-between-cancer-and-heart-physicians-essential-for-breast-cancer-patients-receiving-radiation-therapy.aspxA new report showing that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk.Dana-Farber Cancer Institute03/13/2013http://www.dana-farber.org/Newsroom/News-Releases/Looking-for-the-best-foods-to-fight-cancer-Head-to-the-produce-aisle.aspxDuring National Nutrition Month®, the nutrition team at Dana-Farber Cancer Institute reminds everyone that maintaining a healthy diet that is rich in plant-based foods is one of the best ways to help prevent cancer. Stacy Kennedy, MPH, RD, CSO, LDN, a nutritionist at Dana-Farber, discusses five of her favorite cancer-fighting foods.Dana-Farber Cancer Institute03/12/2013http://www.dana-farber.org/Newsroom/News-Releases/No-excuses-for-skipping-a-colonoscopy-to-screen-for-colorectal-cancer.aspxCharles Fuchs, MD, MPH, director of the Center for Gastrointestinal Oncology at Dana-Farber Cancer Institute, said colorectal cancer can be detected early thanks to one simple screening test, a colonoscopy.Dana-Farber Cancer Institute03/08/2013http://www.dana-farber.org/Newsroom/News-Releases/dfbwcc-and-milford-regional-medical-center-celebrate-fifth-anniversary-of-cancer-center.aspxDana-Farber/Brigham and Women's Cancer Center (DF/BWCC) and Milford Regional Medical Center held a reception to celebrate the five-year anniversary of the cancer center's founding at Milford.Dana-Farber Cancer Institute03/07/2013http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-physicians-recognized-as-Top-Doctors-by-Boston-magazine.aspxFifty-five physicians and surgeons affiliated with Dana-Farber have been named to Boston magazine's annual "Top Doctors" guide.Dana-Farber Cancer Institute03/05/2013http://www.dana-farber.org/Newsroom/News-Releases/study-reveals-how-inherited-risk-factors-in-junk-DNA-affect-breast-cancer-predisposition.aspxDana-Farber scientists have linked genetic variants to the regulation of genes involved in breast cancer, including four genes not previously implicated in breast cancer, shedding new insights into the biology of breast cancer.Dana-Farber Cancer Institute02/26/2013http://www.dana-farber.org/Newsroom/News-Releases/Anderson-underscores-need-for-cancer-research-funding-at-Washington-briefing.aspxKen Anderson, MD, briefed members of Congress and their legislative staffs on blood cancer care and research, and the importance of protecting and enhancing federal research funding.Dana-Farber Cancer Institute02/20/2013http://www.dana-farber.org/Newsroom/News-Releases/Weingart-to-be-honored-with-2012-John-M-Eisenberg-Patient-Safety-and-Quality-Award.aspxThe National Quality Forum and The Joint Commission will recognize Saul N. Weingart, MD, PhD, as a 2012 recipient of the annual John M. Eisenberg Patient Safety and Quality Award.Dana-Farber Cancer Institute02/19/2013http://www.dana-farber.org/Newsroom/News-Releases/study-tracks-genetic-evolution-of-form-of-leukemia.aspxDana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.Dana-Farber Cancer Institute02/14/2013http://www.dana-farber.org/Newsroom/News-Releases/New-strategy-prevents-rheumatoid-arthritis-in-mice.aspxDana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.Dana-Farber Cancer Institute02/08/2013http://www.dana-farber.org/Newsroom/News-Releases/Cupid-takes-on-cancer-with-healthy-Valentines-Day-menu.aspxWhat better way to say "I love you" than with a delicious and healthy meal. Chef Frank McClelland of Boston's four-star restaurant L'Espalier contributes recipes to this romantic dinner. All recipes are available in Dana-Farber's Health Library.Dana-Farber Cancer Institute02/07/2013http://www.dana-farber.org/Newsroom/News-Releases/boston-red-sox-jimmy-fund-partnership-marks-60th-anniversary.aspxThe Boston Red Sox and the Jimmy Fund, which together support adult and pediatric cancer care and research at Dana-Farber Cancer Institute, are celebrating the 60th anniversary of their historic partnership during the upcoming baseball season.Dana-Farber Cancer Institute02/07/2013http://www.dana-farber.org/Newsroom/News-Releases/alexs-lemonade-stand-foundation-awards-1.75-million-grant-to-dfchcc.aspxDana-Farber/Children's Hospital Cancer Center is one of the first three institutions to be named as a Center of Excellence by Alex's Lemonade Stand Foundation.Dana-Farber Cancer Institute01/30/2013http://www.dana-farber.org/Newsroom/News-Releases/researchers-discover-new-mutations-driving-malignant-melanoma.aspxDana-Farber and Broad Institute researchers have identified two mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date.Dana-Farber Cancer Institute01/24/2013http://www.dana-farber.org/Newsroom/News-Releases/Genomic-sequencing-identifies-mutant-drivers-of-common-brain-tumor.aspxScientists from Dana-Farber and the Broad Institute have identified two DNA mutations that appear to drive about 15 percent of meningiomas, a finding that could lead to the first effective drug treatments for the brain tumor.Dana-Farber Cancer Institute01/23/2013http://www.dana-farber.org/Newsroom/News-Releases/national-academy-of-sciences-honors-dfchccs-orkin.aspxStuart H. Orkin, MD, chairman of the department of pediatric oncology at Dana-Farber/Children’s Hospital Cancer Center, will receive the Jessie Stevenson Kovalenko Medal at the National Academy of Sciences’ 150th Annual meeting in April.Dana-Farber Cancer Institute01/15/2013http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-physician-honored-for-exemplary-end-of-life-care-and-leadership.aspxJane deLima Thomas, MD, a palliative care physician and associate director of the Harvard Palliative Medicine Fellowship Program at Dana-Farber Cancer Institute, is one of five U.S. physicians to receive the 2013 Hastings Center Cunniff-Dixon Physician Award.Dana-Farber Cancer Institute01/15/2013http://www.dana-farber.org/Newsroom/News-Releases/study-shows-promise-of-molecular-screening-for-gynecologic-cancers.aspxA new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, a co-author of the commentary on the study, says the test is an important step in that direction.Dana-Farber Cancer Institute01/09/2013http://www.dana-farber.org/Newsroom/News-Releases/Want-to-fight-cancer-with-your-fork-there-s-an-app-for-that.aspxDana-Farber launches a free, easy-to-use Apple iPhone® app that provides recipes and nutrition information that can be searched by cancer patients, cancer survivors, their families, and anyone who wants to have a healthy diet.Dana-Farber Cancer Institute01/08/2013http://www.dana-farber.org/Newsroom/News-Releases/national-report-finds-u-s-cancer-death-rates-continue-to-decline.aspxA report from the nation's leading cancer organizations shows rates of death in the United States from all cancers for men and women continued to decline between 2000 and 2009. The findings come from the latest Annual Report to the Nation on the Status of CancerDana-Farber Cancer Institute01/07/2013http://www.dana-farber.org/Newsroom/News-Releases/Some-men-voice-complaints-of-shortened-penis-following-prostate-cancer-treatment.aspxResearchers at Dana-Farber/Brigham and Women's Cancer Center report a small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.Dana-Farber Cancer Institute01/02/2013http://www.dana-farber.org/Newsroom/News-Releases/Drug-shortage-linked-to-greater-risk-of-relapse-in-young-Hodgkin-lymphoma-patients.aspxA national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.Dana-Farber Cancer Institute12/26/2012http://www.dana-farber.org/Newsroom/News-Releases/cancer-and-the-holidays-five-tips-for-a-less-stressful-season.aspxCoping with cancer during the holidays can turn the season from joyful to stressful and full of anxiety. Here's some advice to help patients and their friends and family cope and celebrate this season.Dana-Farber Cancer Institute12/18/2012http://www.dana-farber.org/Newsroom/News-Releases/patients-with-family-history-of-colorectal-cancer-may-be-at-risk-for-aggressive-form-of-the-disease-study-finds.aspxDana-Farber Cancer Institute researchers report that when people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening.Dana-Farber Cancer Institute12/14/2012http://www.dana-farber.org/Newsroom/News-Releases/Researchers-find-new-culprit-in-castration-resistant-prostate-cancer.aspxDana-Farber scientists have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, a finding that could serve as a treatment target for castration-resistant prostate cancers.Dana-Farber Cancer Institute12/14/2012http://www.dana-farber.org/Newsroom/News-Releases/Potential-gene-therapy-approach-to-sickle-cell-disease-highlighted-at-national-hematology-meeting.aspxResearchers at Dana-Farber/Children's Hospital Cancer Center have taken the first preliminary steps toward developing a form of gene therapy for sickle cell disease.Dana-Farber Cancer Institute12/11/2012http://www.dana-farber.org/Newsroom/News-Releases/Intensified-chemotherapy-shows-promise-for-children-with-very-high-risk-form-of-leukemia.aspxPediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.Dana-Farber Cancer Institute12/10/2012http://www.dana-farber.org/Newsroom/News-Releases/experimental-graft-versus-host-disease-treatment-equivalent-to-standard-care-in-phase-3-trial.aspxDana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.Dana-Farber Cancer Institute12/10/2012http://www.dana-farber.org/Newsroom/News-Releases/blood-levels-of-immune-protein-predict-risk-in-hodgkin-disease.aspxDana-Farber researchers found levels of galectin-1, an immunity-related protein, could be the basis of a test, and potentially a targeted treatment for Hodgkin lymphoma.Dana-Farber Cancer Institute12/10/2012http://www.dana-farber.org/Newsroom/News-Releases/Polyak-honored-at-35th-annual-San-Antonio-Breast-Cancer-Symposium.aspxKornelia Polyak, MD, PhD, was presented with the 2012 AACR Outstanding Investigator Award for Breast Cancer Research at the 35th annual CTRC-AACR San Antonio Breast Cancer Symposium.Dana-Farber Cancer Institute12/07/2012http://www.dana-farber.org/Newsroom/News-Releases/researchers-discover-regulator-linking-exercise-to-bigger-stronger-muscles.aspxScientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein’s levels might someday help prevent muscle loss caused by cancer, prolonged inactivity in hospital patients, and aging.Dana-Farber Cancer Institute12/06/2012http://www.dana-farber.org/Newsroom/News-Releases/Six-healthy-holiday-party-foods-and-recipes.aspxThe holidays are here and so is all the festive food. Some of it is naughty but much of it can be nice. "Many of the foods we enjoy around the holidays are not only delicious to eat, but they may also contain cancer-fighting nutrients," says Stacy Kennedy, MPH, RD, CSO, LDN, a nutritionist at Dana-Farber Cancer Institute.Dana-Farber Cancer Institute12/04/2012http://www.dana-farber.org/Newsroom/News-Releases/researchers-report-first-success-of-targeted-therapy-in-most-common-genetic-subtype-of-non-small-cell-lung-cancer.aspxA new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.Dana-Farber Cancer Institute11/27/2012http://www.dana-farber.org/Newsroom/News-Releases/New-oral-drug-overcomes-resistance-in-patients-with-rare-sarcoma-after-failure-of-standard-targeted-therapies.aspxA new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber who led the worldwide clinical trial.Dana-Farber Cancer Institute11/21/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-compounds-or-creates-medication-tailored-for-individual-patients.aspxSylvia Bartel, RPh, MHP, vice president of Pharmacy Services at Dana-Farber, talks about medication safety following news of a recent meningitis outbreak at a Massachusetts-based compounding center. Bartel explains Dana-Farber is one of only a handful of hospitals in the Boston area that compounds or creates medication tailored specifically for individual patients.Dana-Farber Cancer Institute11/15/2012http://www.dana-farber.org/Newsroom/News-Releases/Five-fall-foods-that-fight-cancer.aspxStacy Kennedy, MPH, RD, CSO, LDN, a senior nutritionist at Dana-Farber, says many cancer-fighting foods are at their nutritional peak in the fall and it's a good time to incorporate them into a healthy diet. She explains what to look for and offers easy-to-prepare recipes.Dana-Farber Cancer Institute11/15/2012http://www.dana-farber.org/Newsroom/News-Releases/five-things-to-know-about-lung-cancer.aspxBruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.Dana-Farber Cancer Institute11/14/2012http://www.dana-farber.org/Newsroom/News-Releases/terminally-ill-cancer-patients-who-discuss-end-of-life-care-early-can-avoid-needlessly-aggressive-treatment.aspxA new study by Dana-Farber researchers shows terminally ill cancer patients who have an early talk with their physician about care at the end-of-life are less likely to receive aggressive therapy – and more likely to enter hospice care – than patients who delay such discussions until the days and weeks before death.Dana-Farber Cancer Institute11/13/2012http://www.dana-farber.org/Newsroom/News-Releases/dana-Farber-offers-web-communities-for-cancer-patients-survivors-and-families.aspxDana-Farber is providing cancer patients and survivors, and their families, access to more than 60 diseases-specific online communities that enables them to connect with others in a private, confidential, and secure environment.Dana-Farber Cancer Institute10/31/2012http://www.dana-farber.org/Newsroom/News-Releases/Gene-mutation-identifies-colorectal-cancer-patients-who-live-longer-with-aspirin-therapy-study-finds.aspxA new study by Dana-Farber researchers shows aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation.Dana-Farber Cancer Institute10/24/2012http://www.dana-farber.org/Newsroom/News-Releases/Advanced-cancer-patients-overoptimistic-about-chemotherapys-ability-to-cure-study-finds.aspxDana-Farber Cancer Institute researchers report findings from a nationwide study that suggest that advanced lung or colorectal cancer patients are frequently mistaken in their beliefs that chemotherapy can cure their disease.Dana-Farber Cancer Institute10/24/2012http://www.dana-farber.org/Newsroom/News-Releases/If-you-like-Dana-Farber-you-could-love-a-New-England-Patriots-jersey-autographed-by-Brady.aspxPeople who "like" Dana-Farber on Facebook will be entered to win an official NFL New England Patriots jersey autographed by Brady.Dana-Farber Cancer Institute10/18/2012http://www.dana-farber.org/Newsroom/News-Releases/fact-or-fiction-whats-the-truth-about-breast-cancer-risk.aspxWendy Chen, MD, MPH, a breast cancer expert at Dana-Farber Cancer Institute helps tackles some of the myths and misconceptions about breast cancer risk. She answers some of the more common questions, explains the studies behind the answers, and provides risk-lowering tips.Dana-Farber Cancer Institute10/18/2012http://www.dana-farber.org/Newsroom/News-Releases/Targeting-cancers-addiction-to-cell-cycle-proteins-shuts-down-tumors-in-mice.aspxDana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."Dana-Farber Cancer Institute10/17/2012http://www.dana-farber.org/Newsroom/News-Releases/dana-farber-expert-offers-five-ways-to-reduce-your-breast-cancer-risk.aspxErica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.Dana-Farber Cancer Institute10/12/2012http://www.dana-farber.org/Newsroom/News-Releases/New-tool-determines-leukemia-cells-readiness-to-die-may-guide-clinical-care.aspxDana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.Dana-Farber Cancer Institute10/11/2012http://www.dana-farber.org/Newsroom/News-Releases/DF-CHCC-establishes-training-program-with-Egypt-Cancer-Network-and-Childrens-Cancer-Hospital-Egypt.aspxDana-Farber/Children's Hospital Cancer Center physicians and nurses are collaborating to create an Egypt-based fellowship training program in pediatric oncology.Dana-Farber Cancer Institute09/21/2012http://www.dana-farber.org/Newsroom/News-Releases/researchers-identify-three-subtypes-of-high-grade-serous-ovarian-cancer.aspxResearch led by Dana-Farber Cancer Institute scientists may soon enable doctors to determine which patients with the most common form of ovarian cancer – high-grade serous ovarian cancer (HGSOC) – are most likely to benefit from a certain class of drugs.Dana-Farber Cancer Institute09/19/2012http://www.dana-farber.org/Newsroom/News-Releases/september-is-ovarian-cancer-awareness-month.aspxDana-Farber/Brigham and Women's Cancer Center and the Massachusetts Ovarian Cancer Awareness Coalition want women to get the facts and recognize the signs of the disease.Dana-Farber Cancer Institute09/18/2012http://www.dana-farber.org/Newsroom/News-Releases/Predictive-molecular-signature-in-lymphoma-may-direct-targeted-therapy.aspxDana-Farber researchers have found a genetic signature in tumors to help them determine if diffuse large B cell lymphoma patients will benefit more from traditional therapies or targeted therapies.Dana-Farber Cancer Institute09/14/2012http://www.dana-farber.org/Newsroom/News-Releases/Molecule-shows-effectiveness-against-drug-resistant-myeloma.aspxDana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.Dana-Farber Cancer Institute09/11/2012http://www.dana-farber.org/Newsroom/News-Releases/new-potential-targets-discovered-for-treating-squamous-cell-lung-cancers.aspxThe Cancer Genome Atlas Research Network has identified a large number and variety of DNA alterations in squamous cell lung cancer tumors, which could serve as potential therapeutic targets for treating the second most common type of lung cancer.Dana-Farber Cancer Institute09/09/2012http://www.dana-farber.org/Newsroom/News-Releases/stand-up-to-cancer-returns-to-primetime-sept-seventh.aspxThe SU2C program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.Dana-Farber Cancer Institute09/04/2012http://www.dana-farber.org/Newsroom/News-Releases/a-male-contraceptive-pill-in-the-making.aspxA new study by researchers at Dana-Farber shows a small molecule compound called JQ1 can generate reversible birth control in male mice.Dana-Farber Cancer Institute08/16/2012http://www.dana-farber.org/Newsroom/News-Releases/Red-Sox-announce-August-as-Jimmy-Fund-Month.aspxThe Boston Red Sox and the Red Sox Foundation have declared August to be "Jimmy Fund Month" in recognition of the organizations' longstanding partnership with the Jimmy Fund and Dana-Farber Cancer Institute.Dana-Farber Cancer Institute08/07/2012http://www.dana-farber.org/Newsroom/News-Releases/senator-scott-brown-visit-dana-farber-zakim-center-before-pmc-ride.aspxSenator Scott Brown, who is riding in his third PMC this weekend as a member of “Team Lenny,” visited the Leonard P. Zakim Center for Integrative Therapies at Dana-Farber this morning.Dana-Farber Cancer Institute08/03/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-creates-finger-friendly-mobile-website-for-those-on-the-go.aspxDana-Farber Cancer Institute has launched a mobile version of its website to provide fast and easy access to information to smartphone users about Dana-Farber's cancer care programs and related services.Dana-Farber Cancer Institute07/30/2012http://www.dana-farber.org/NewsRoom/News-Releases/going-viral-proteins-identify-potential-cancer-related-genes.aspxIn a study published in the journal Nature, researchers at Dana-Farber Cancer Institute and an international team of associates used a technique involving viral proteins to prioritize which of the many mutated genes in tumor cells are likely involved in cancer and which are mere bystanders.Dana-Farber Cancer Institute07/30/2012http://www.dana-farber.org/Newsroom/News-Releases/key-mutations-discovered-for-most-common-childhood-brain-cancer.aspxDana-Farber/Children's Hospital Cancer Center researchers have linked genetic mutations to each of the four recognized subtypes of medulloblastoma, the most common malignant brain tumor of children.Dana-Farber Cancer Institute07/26/2012http://www.dana-farber.org/Newsroom/News-Releases/US-News-ranks-Dana-Farber-Brigham-and-Womens-Cancer-Center-top-cancer-hospital-in-New-England-and-fifth-highest-in-country.aspxU.S. News & World Report's Best Hospitals guide has ranked Dana-Farber/Brigham and Women's Cancer Center the top cancer center in New England and fifth overall in the country.Dana-Farber Cancer Institute07/17/2012http://www.dana-farber.org/Newsroom/News-Releases/newly-isolated-beige-fat-cells-could-help-fight-obesity.aspxDana-Farber Cancer Institute researchers have isolated a new type of energy-burning fat cell called "beige fat" in adult humans which they say may have therapeutic potential for treating obesity.Dana-Farber Cancer Institute07/12/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-named-to-national-Myelodysplastic-Syndromes-consortium.aspxDavid Steensma, MD, leads Dana-Farber's efforts as part of a six-institution, $16 million research consortium advancing the treatments and outcomes for patients suffering from Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood.Dana-Farber Cancer Institute07/11/2012http://www.dana-farber.org/Newsroom/News-Releases/Tumor-microenvironment-helps-skin-cancer-cells-resist-drug-treatment.aspxDana-Farber researchers are studying melanoma tumors' microenvironments to better understand how some melanoma continue to grow and survive despite the presence of anti-cancer drugs.Dana-Farber Cancer Institute07/05/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-expresses-gratitude-for-BAA-s-Guy-Morse.aspxMore than 20 years ago, Guy Morse made the Boston Athletic Association's Boston Marathon®, one of the world's premier athletic events, even more exceptional by opening it to charitable organizations like Dana-Farber Cancer Institute.Dana-Farber Cancer Institute06/25/2012http://www.dana-farber.org/Newsroom/News-Releases/Breast-cancer-s-many-drivers.aspxIn one of the largest breast cancer sequencing efforts to date, scientists from Dana-Farber and their colleagues have discovered surprising alterations in genes that were not previously associated with breast cancer.Dana-Farber Cancer Institute06/20/2012http://www.dana-farber.org/Newsroom/News-Releases/Stem-Cell-Transplant-the-only-definitive-treatment-for-myelodysplastic-syndrome.aspxThe pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.Dana-Farber Cancer Institute06/13/2012http://www.dana-farber.org/Newsroom/News-Releases/New-targeted-therapy-effective-in-patients-with-drug-resistant-metastatic-gastrointestinal-stromal-tumor.aspxRegorafenib was found to reduce the risk of disease progression or death by more than 70 percent in patients whose tumors had become resistant to Gleevec and Sutent.Dana-Farber Cancer Institute06/04/2012http://www.dana-farber.org/Newsroom/News-Releases/Study-reports-first-success-of-targeted-therapy-in-most-common-genetic-subtype-of-non-small-cell-lung-cancer.aspxDana-Farber researchers report a novel compound has become the first targeted therapy to benefit patients with non-small cell lung cancer.Dana-Farber Cancer Institute05/31/2012http://www.dana-farber.org/Newsroom/News-Releases/New-strategy-directly-activates-cellular-death-protein.aspxResearchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells — which could lead to new possibilities for designing cancer drugs.Dana-Farber Cancer Institute05/31/2012http://www.dana-farber.org/Newsroom/News-Releases/New-drug-strategy-attacks-resistant-leukemia-and-lymphoma.aspxResearchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.Dana-Farber Cancer Institute05/29/2012http://www.dana-farber.org/Newsroom/News-Releases/Reverse-engineering-epilepsy-s-miracle-diet.aspxThe discovery of a connection between seizure resistance and a protein that modifies metabolism in the brain may result in a new treatment for epilepsy that parallels the results of the ketogenic diet, say researchers from Dana-Farber and Harvard Medical School.Dana-Farber Cancer Institute05/24/2012http://www.dana-farber.org/Newsroom/News-Releases/Novel-treatment-exposes-melanoma-to-immune-system-attack.aspxA clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.Dana-Farber Cancer Institute05/23/2012http://www.dana-farber.org/Newsroom/News-Releases/Hormone-depleting-drug-shows-promise-against-localized-high-risk-prostate-tumors.aspxDana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.Dana-Farber Cancer Institute05/16/2012http://www.dana-farber.org/Newsroom/News-Releases/Paths-of-Progress-app-expands-to-Android-and-Kindle-Fire.aspxPaths of Progress, Dana-Farber’s award-winning cancer research magazine, is now available as a free app for iPad, Android and Kindle Fire tablets.Dana-Farber Cancer Institute05/15/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-Cancer-Institute-recognizes-Oncology-Nursing-Month.aspxDuring Oncology Nursing Month, Dana-Farber proudly recognizes its dedicated, expert nursing professionals, who serve many functions along the continuum of care. Our nurses also received recognition from national peers and local patients.Dana-Farber Cancer Institute05/14/2012http://www.dana-farber.org/Newsroom/News-Releases/new-under-the-sun-recurrent-genetic-mutations-in-melanoma.aspxScientists from Dana-Farber and the Broad Institute have sequenced 25 melanoma tumors and confirmed the long-held suspicion that chronic sun exposure plays a role in skin cancer.Dana-Farber Cancer Institute05/09/2012http://www.dana-farber.org/Newsroom/News-Releases/american-society-for-clinical-investigation-honors-kaelin.aspxWilliam G. Kaelin, Jr., MD, received the 2012 American Society for Clinical Investigation’s Stanley J. Korsmeyer Award in recognition of his contributions to the molecular understanding of cellular oxygen sensing and cellular adaptation to hypoxia.Dana-Farber Cancer Institute05/02/2012http://www.dana-farber.org/Newsroom/News-Releases/advanced-pancreatic-tumors-depend-on-continued-oncogene-activity.aspxDana-Farber researchers report that advanced pancreatic cancers are dependent on the continued expression of a mutant oncogene that "rewires" key metabolic pathways, which suggests that these altered pathways might be potential targets for future drugs.Dana-Farber Cancer Institute04/30/2012http://www.dana-farber.org/Newsroom/News-Releases/adding-drug-to-standard-chemotherapy-provides-no-survival-benefit-for-older-lung-cancer-patients.aspxAdding Avastin to standard chemotherapy treatment may not improve survival rates for people with non-small cell lung cancer aged 65 plus, according to Dana-Farber researchers, who further suggest that clinicians exercise caution in including the drug in treatment recommendations.Dana-Farber Cancer Institute04/17/2012http://www.dana-farber.org/Newsroom/News-Releases/social-ties-have-mixed-impact-on-encouraging-healthy-behaviors-in-low-income-areas.aspxStrong social connections may make it harder for some people who live in low-income, minority communities to lead a healthy lifestyle,
report Dana-Farber and Harvard School of Public Health researchers.Dana-Farber Cancer Institute04/13/2012http://www.dana-farber.org/Newsroom/News-Releases/dana-farber-unveils-contemporary-art-collection-audio-tour.aspxDana-Farber is further enhancing the patient experience with a contemporary art collection of nearly 500 works by both local and internationally renowned artists throughout the Yawkey Center. A new audio guide allows cancer patients and families to learn more about the artwork.Dana-Farber Cancer Institute04/11/2012http://www.dana-farber.org/newsroom/news-releases/first-targeted-nanomedicine-to-enter-cancer-clinical-studies.aspxA multi-institutional team of researchers has published a study that demonstrates a novel therapy works against solid tumors. It is the first targeted and programmed nanomedicine to enter human clinical studies.Dana-Farber Cancer Institute04/06/2012http://www.dana-farber.org/newsroom/news-releases/american-association-for-cancer-research-honors-dandrea.aspxThe American Association for Cancer Research named Alan D. D'Andrea, MD, the recipient of the 52nd Annual AACR G.H.A. Clowes Memorial Award for his work in understanding cancer survival and progression.Dana-Farber Cancer Institute04/06/2012http://www.dana-farber.org/Newsroom/News-Release/stand-up-to-cancer-and-prostate-cancer-foundation-announce-new-dream-team.aspxA new SU2C and Prostate Cancer Foundation Dream Team, dedicated to advanced prostate cancer research, includes two Dana-Farber researchers among scientists from leading prostate cancer centers in the U.S. and England.Dana-Farber Cancer Institute04/02/2012http://www.dana-farber.org/newsroom/news-releases/writing-the-book-of-cancer-knowledge.aspxDana-Farber scientists and colleagues have published results from the Cancer Cell Line Encyclopedia, a resource that marries cancer genome data with predictors of drug responses. This information could refine cancer clinical trials and future treatments.Dana-Farber Cancer Institute03/30/2012http://www.dana-farber.org/Newsroom/News-Releases/us-cancer-death-rates-continue-to-decline-national-report-finds.aspxDana-Farber president Edward J. Benz, MD, comments on a report showing decline in rates of death in the U.S. from all cancers for men and women. The findings come from the latest Annual Report to the Nation on the Status of Cancer.Dana-Farber Cancer Institute03/28/2012http://www.dana-farber.org/Newsroom/News-Releases/co-clinical-trials-help-focus-lung-cancer-research.aspxBy conducting simultaneous clinical trials in patients and labs, Dana-Farber researchers and colleagues have been able to predict how patients with non-small cell lung cancer respond to combination therapy.Dana-Farber Cancer Institute03/28/2012http://www.dana-farber.org/Newsroom/News-Releases/DNA-marker-predicts-platinum-drug-response-in-breast-ovarian-cancer.aspxScientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.Dana-Farber Cancer Institute03/23/2012http://www.dana-farber.org/Newsroom/News-Releases/Colon-cancer-on-the-rise-in-young-adults.aspxColorectal cancer is the second leading cause of cancer deaths in the United States. Many people have no symptoms in the early stages of the disease. Doctors are reminding people about the importance of being regularly screened to help save lives.Dana-Farber Cancer Institute03/07/2012http://www.dana-farber.org/newsroom/news-releases/belfer-institute-for-applied-cancer-science-appoints-head-of-research.aspxJessie M. English, PhD, has been appointed the head of Research of the Belfer Institute for Applied Cancer Science at Dana-Farber. The Belfer Institute offers the full array of innovative drug discovery capabilities, from the identification of cancer-causing genetic mutations to the validation and selection of new drug targets.Dana-Farber Cancer Institute03/01/2012http://www.dana-farber.org/Newsroom/News-Releases/new-subtype-of-ovarian-cancer-may-be-vulnerable-to-anti-angiogenic-drugs.aspxThe discovery of a subtype of ovarian cancer that could account for up to one-third of all serous ovarian cancers may lead to clinical trials using anti-angiogenic drugs that are already being tested in other cancers.Dana-Farber Cancer Institute02/15/2012http://www.dana-farber.org/Newsroom/News-Releases/justin-bieber-dream-date-shines-light-on-rare-pediatric-cancer.aspxJustin Bieber's date with young brain tumor patient Avalanna Routh has focused attention on atypical teratoid rhabdoid tumor, or AT/RT. Mark Kieran, MD, PhD, of Dana-Farber/Children's Hospital Cancer Center, discusses this rare cancer.
Dana-Farber Cancer Institute02/14/2012http://www.dana-farber.org/Newsroom/News-Releases/newly-identified-fusion-genes-in-lung-and-colorectal-cancer-may-guide-treatment-with-targeted-drugs.aspxNewly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.Dana-Farber Cancer Institute02/13/2012http://www.dana-farber.org/Newsroom/News-Releases/cupid-takes-on-cancer.aspxWith Valentine's Day around the corner, show that special someone how much you care. Dana-Farber nutritionist Stephanie Meyers shares ways to say "I love you" with delicious desserts packed with the cancer-fighting phytonutrients in raspberries, pomegranates, berries, and mango.Dana-Farber Cancer Institute02/10/2012http://www.dana-farber.org/Newsroom/News-Releases/most-terminally-ill-cancer-patients-discuss-end-of-life-care-with-physician-study-finds.aspxA study led by Jennifer Mack, MD, MPH, suggests that many terminally ill cancer patients do talk with a doctor about their preferences for end-of-life care, but those conversations often occur late in the course of their illness and tend to be with a hospital-based physician and not their oncologist who has been caring for them.Dana-Farber Cancer Institute02/08/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-Childrens-Hospital-Cancer-Center-experts-recommend-genetic-counseling-for-pediatric-sarcoma-patients.aspxGenetic specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) are recommending that children being treated for sarcoma should be offered genetic counseling for Li-Fraumeni syndrome, a rare condition that greatly raises a person’s risk of developing additional cancersDana-Farber Cancer Institute02/08/2012http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-appoints-Partridge-as-director-of-adult-survivorship-program.aspxAnn Partridge, MD, MPH, is named the director of Dana-Farber's Adult Survivorship Program and the Lance Armstrong Foundation Clinic. An accomplished clinician-researcher, Partridge is nationally recognized for contributions to the fields of breast cancer in young women and cancer survivorship.Dana-Farber Cancer Institute02/07/2012http://www.dana-farber.org/Newsroom/News-Releases/three-targeted-cancer-drugs-raise-risk-of-fatal-side-effects.aspxTreatment with three "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber. These risks remain low, but they should be factored in when developing patients’ treatment plans.Dana-Farber Cancer Institute02/06/2012http://www.dana-farber.org/Newsroom/News-Releases/World-Cancer-Day-points-to-prevention.aspxWorld Cancer Day is Saturday, February 4th. Focusing on this year's theme of prevention, Dana-Farber's Judy Garber, MD, MPH, says simple lifestyle changes can reduce your cancer risk.Dana-Farber Cancer Institute02/03/2012http://www.dana-farber.org/Newsroom/News-Releases/sunscreen-still-applies-in-winter-months.aspxIt's still possible to get too much sun exposure in winter. Dana-Farber's skin cancer specialists explain the dangers and offer sun safety tips to help you protect your skin while enjoying outdoor winter activities.Dana-Farber Cancer Institute02/01/2012http://www.dana-farber.org/Newsroom/News-Releases/Massachusetts-Life-Sciences-Center-grant-expands-Dana-Farber-s-cancer-imaging-research-program.aspxThe Massachusetts Life Sciences Center has awarded Dana-Farber Cancer Institute a $10 million grant to support the expansion of its pioneering cancer imaging research program with a new imaging facility which will support more rapid assessment of therapies and play a key role in the delivery of personalized medicine.Dana-Farber Cancer Institute01/31/2012http://www.dana-farber.org/Newsroom/News-Releases/-Pulverized--chromosomes-linked-to-cancer-.aspxIn a paper published online yesterday by the journal Nature, Dana-Farber researchers map out a mechanism by which micronuclei could potentially disrupt the chromosomes within them and produce cancer-causing gene mutations. The findings may point to a vulnerability in cancer cells that could be attacked by new therapies.Dana-Farber Cancer Institute01/19/2012http://www.dana-farber.org/Newsroom/News-Releases/New-iPad-app-brings-Paths-of-Progress-to-life.aspxDana-Farber is expanding its digital publishing efforts with the launch of Paths of Progress, the Institute's twice-yearly research and care magazine, as an iPad application enhanced with animations and web links.Dana-Farber Cancer Institute01/18/2012http://www.dana-farber.org/Newsroom/News-Releases/Researchers-isolate-messenger-protein-linking-exercise-to-health-benefits.aspxResearchers have isolated a natural hormone from muscle cells that triggers some of the key health benefits of exercise. Irisin, which switches on genes that convert white fat into "good" brown fat, may hold promise as a novel treatment for diabetes, obesity and perhaps other disorders, including cancer.Dana-Farber Cancer Institute01/11/2012http://www.dana-farber.org/Newsroom/News-Releases/Ring-in-a-new-healthier-you-in-2012.aspxAre you making New Year's resolutions? Dana-Farber Cancer Institute experts are encouraging people to ring in new healthy habits in 2012. Here are a number of free and low-cost strategies to help people maintain good health and possibly reduce various cancer risks.Dana-Farber Cancer Institute12/28/2011http://www.dana-farber.org/Newsroom/News-Releases/Targeting-EETs-to-treat-cardiovascular-disease-may-prove-a-double-edged-sword.aspxA study documents the connection between increased levels of epoxyeicosatrienoic acids (EET) lipids and cancer growth and metastasis opening the door to a new avenue for cancer treatment.Dana-Farber Cancer Institute12/19/2011http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-offers-healthy-holiday-recipes-and-food-tips.aspxThe holidays are a great time to bring cancer-fighting foods to the table. Nutritionist Stephanie Meyers, MS, RD/LDN, discusses some holiday favorites that also contain cancer-preventing nutrients and shares recipes that highlight these beneficial ingredients.Dana-Farber Cancer Institute12/15/2011http://www.dana-farber.org/Newsroom/News-Releases/Former-Dana-Farber-president-receives-lifetime-achievement-award.aspxDavid G. Nathan, MD, president emeritus of Dana-Farber, was bestowed with the highest honor give by the American Society of Hematology: the Wallace H. Coulter Award for Lifetime Achievement in Hematology.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/Therapy-improves-stem-cell-engraftment-in-umbilical-cord-blood-transplant-recipients.aspxA therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/Massive-DNA-search-uncovers-new-mutations-driving-blood-cancer.aspxResearchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/peptide-cocktail-elicits-immune-response-to-multiple-myeloma.aspxScientists have created a "cocktail" combination of four antigenic peptides derived from myeloma cells they believe could provoke the body's defenses to attack multiple myeloma in its early "smoldering" phase and slow or prevent the blood cancer.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/researchers-identify-genetic-mutation-responsible-for-most-cases-of-waldenstroms-macroglobulinemia.aspxScientists at Dana-Farber Cancer Institute have identified a gene mutation that underlies the vast majority of cases of Waldenström's macroglobulinemia, a rare form of lymphoma that has eluded all previous efforts to find a genetic cause.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/Experimental-drug-combination--encouraging--in-relapsed-multiple-myeloma.aspxA phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising treatment for patients with advanced multiple myeloma when the targeted drug bortezomib stops working alone.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/twinning-us-based-and-rwandan-physicians-improves-lymphoma-outcomes-in-children.aspx"Twinning" U.S.-based and Rwandan physicians in a team approach has shown to improve lymphoma outcomes in children in a country lacking any specialists in children's cancers.Dana-Farber Cancer Institute12/12/2011http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-launches-cancer-blog.aspxDana-Farber has launched Insight, a new blog providing expert commentary on cancer research news, patient care, and issues relevant to people with cancer and their families.Dana-Farber Cancer Institute12/09/2011http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-a-novel-therapeutic-approach-for-liver-cancer.aspxResearchers have identified a mechanism that triggers inflammation in the liver and transforms normal cells into cancerous ones, a finding that could lead to the treatment or prevention of liver cancer.Dana-Farber Cancer Institute12/09/2011http://www.dana-farber.org/Newsroom/News-Releases/Boston-magazine-recognizes-Dana-Farber-physicians-as--Top-Doctors-.aspxBoston magazine has named 56 physicians and surgeons affiliated with Dana-Farber Cancer Institute to its Top Doctors guide. Published in the magazine’s December issue, the Top Doctors list consists of 650 Boston-area physicians from 57 medical specialties.Dana-Farber Cancer Institute12/07/2011http://www.dana-farber.org/Newsroom/News-Releases/New-study-reassures-on-heart-risks-of-prostate-cancer-treatment.aspxHormone-blocking therapy for prostate cancer doesn’t raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women’s Cancer Center.Dana-Farber Cancer Institute12/06/2011http://www.dana-farber.org/Newsroom/News-Releases/New-England-Patriots-Charitable-Foundation-kicks-off-blood-and-platelet-drive--at-Dana-Farber-and-Brigham-and-Women-s-Hospital.aspxThe New England Patriots Charitable Foundation continues their efforts to increase awareness of the importance of blood and platelet donations with a drive December 1 through December 31, at the Dana-Farber Cancer Institute Kraft Family Blood Donor Center and the Brigham and Women's Hospital Blood Donor Center, both in the Longwood Medical Area.Dana-Farber Cancer Institute12/01/2011http://www.dana-farber.org/Newsroom/News-Releases/New-approach-to-graft-versus-host-disease-treatment-results-in-sustained-improvement-for-some-patients.aspxIn a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.Dana-Farber Cancer Institute11/30/2011http://www.dana-farber.org/Newsroom/News-Releases/Study-identifies-possible-therapy-for-radiation-sickness.aspxA combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital BostonDana-Farber Cancer Institute11/23/2011http://www.dana-farber.org/Newsroom/News-Releases/Sam-Donaldson-speaks-at-Dana-Farber-Visiting-Committee-Symposium-dinner.aspxABC News' Sam Donaldson shared his experience as a melanoma patient during his keynote speech at the Dana-Farber Cancer Institute Joint Visiting Committee Symposium dinner Nov. 15.Dana-Farber Cancer Institute11/21/2011http://www.dana-farber.org/Newsroom/News-Releases/Flash-mob-music-performance-strikes-the-right-chord-at-Dana-Farber.aspxPatients and staff at Dana-Farber Cancer Institute were treated to a surprise performance by Boston's Longwood Symphony Orchestra. Ten musicians took time out their busy days to offer a little "music therapy" with the "flash mob" performance of Bach's Brandenburg Concerto No. 3.Dana-Farber Cancer Institute11/18/2011http://www.dana-farber.org/Newsroom/News-Releases/Pan-Massachusetts-Challenge-Gives-$35-million-to-Jimmy-Fund.aspxOn Friday, Nov. 11, the Pan-Massachusetts Challenge (PMC) presents a check for $35 million to Dana-Farber Cancer Institute through its Jimmy Fund. This year's event involved 5,169 cyclists from eight countries and 37 states.Dana-Farber Cancer Institute11/11/2011http://www.dana-farber.org/Newsroom/News-Releases/Yawkey-Center-for-Cancer-Care-s-green-design-earns-gold.aspxThe U.S. Green Building Council awarded Dana-Farber's Yawkey Center for Cancer Care its Leadership in Energy and Environmental Design (LEED®) Gold certification in recognition of its sustainable and green design and construction features.Dana-Farber Cancer Institute10/31/2011http://www.dana-farber.org/Newsroom/News-Releases/Research-makes-it-possible-to-predict-how-cancers-will-respond-to-chemo.aspxDana-Farber scientists have devised a test that can predict how effective chemotherapy will be by determining whether tumor cells are "primed" for death. The discovery suggests it may be possible to predict which patients will likely benefit from chemo, as well as to make some chemo more effective.Dana-Farber Cancer Institute10/27/2011http://www.dana-farber.org/Newsroom/News-Releases/CDC-guidelines-for-vaccinating-boys-against-HPV-applauded.aspxHead and neck cancer expert Robert Haddad, MD, comments on the CDC's recommendation that boys should be vaccinated against the human papillomavirus (HPV).Dana-Farber Cancer Institute10/25/2011http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber,-Brigham-and-Women-s-launch-Profile,-a-large-scale-research-program-to-scan-tumors-for-mutations,-establish-extensive-genomic-database.aspxDana-Farber and Brigham and Women's Hospital have launched Profile, one of the most comprehensive cancer research studies to help accelerate the development of personalized treatments for every person with cancer.Dana-Farber Cancer Institute10/24/2011http://www.dana-farber.org/Newsroom/News-Releases/Researchers-find-possible-link-between-bacterium-and-colon-cancer.aspxDana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.Dana-Farber Cancer Institute10/17/2011http://www.dana-farber.org/Newsroom/News-Releases/Dialing-up-fetal-hemoglobin-dials-down-sickle-cell-disease.aspxDana-Farber Cancer Institute and Children's Hospital Boston researchers have identified a protein that could be a powerful treatment target for sickle cell anemia, a significant global health problem, one that affects between 75,000 and 100,000 people in the United States alone.Dana-Farber Cancer Institute10/13/2011http://www.dana-farber.org/Newsroom/News-Releases/Childhood-leukemia-survivors-face-lifelong-health-challenges.aspxTens of thousands of childhood cancer survivors are now in their 20s, 30s, and beyond, facing life-long risks of treatment-related health issues. Increasingly, primary care physicians will need to be knowledgeable about symptoms and complaints that might be related to cancer treatments their patients received decades ago.Dana-Farber Cancer Institute10/12/2011http://www.dana-farber.org/Newsroom/News-Releases/New-prostate-cancer-screening-guidelines-called-into-question.aspxDr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.Dana-Farber Cancer Institute10/07/2011http://www.dana-farber.org/Newsroom/News-Releases/Study-finds-key-to-drug-resistance.aspxA new discovery by Jean Zhao, PhD, and colleagues may help physicians predict which tumors are likely to become resistant to a given drug. In the report, published by Nature Medicine, researchers described how they created a genetically engineered mouse model of human breast cancer in which the most frequently occurring breast cancer oncogene, PIK3CA, could be turned on and off.Dana-Farber Cancer Institute09/23/2011http://www.dana-farber.org/Newsroom/News-Releases/Cancer-protein-s-surprising-role-as-memory-regulator.aspxA Dana-Farber and Harvard Medical School study has found that a protein with well-documented ties to cancer also plays a crucial role in memory formation in the brain, and it may be linked to Alzheimer's disease.Dana-Farber Cancer Institute09/22/2011http://www.dana-farber.org/Newsroom/News-Releases/Charlie-s-Story–Thriving-after-Leukemia-and-Relapse.aspxWhen Charlie was diagnosed with acute lymphoblastic leukemia at age 4, his mother sent regular email updates to her large family and circle of friends. Her reflections grew into a touching chronicle of four years in the life of a child with cancer.Dana-Farber Cancer Institute09/15/2011